XI’AN, China, May 15, 2025 — Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading provider of bio-ingredient solutions for the natural, health, and personal care sectors, announced today a 1-for-25 reverse stock split (“Reverse Stock Split”) of its Class A ordinary shares, with a par value of $0.001 per share. The Reverse Stock Split will take effect at 12:01 a.m. Eastern Time on May 19, 2025. At that time, every 25 issued and outstanding Class A ordinary shares will be automatically converted into one new Class A ordinary share. Proportional adjustments will be applied to outstanding equity awards, warrants, and convertible notes, as well as to the number of shares issued and issuable under the Company’s stock incentive plans and certain existing agreements. No fractional shares will be issued; all fractional shares will be rounded up to the nearest whole share. The Reverse Stock Split will uniformly affect all Class A holders and will not change any stockholder’s percentage ownership in the Company.

Bon’s Class A ordinary shares will continue to be listed on The Nasdaq Capital Market under the ticker symbol “BON” and will begin trading on a split-adjusted basis when the market opens on May 19, 2025. The new CUSIP number for the Class A ordinary shares after the Reverse Stock Split will be G14492204.

The primary purpose of the Reverse Stock Split is to bring the Company into compliance with Nasdaq’s $1.00 minimum bid price requirement for continued listing. However, there is no guarantee that the Company will meet this minimum bid price requirement.

Immediately after the Reverse Split, the company’s authorized share capital will increase to (i) 1,000,000,000 Class A ordinary shares, par value $0.025 per share; (ii) 50,000,000 Class B ordinary shares, par value $0.001 per share; and (iii) 50,000,000 preference shares, par value $0.001 per share.

In addition to the Reverse Split and the increase in authorized shares, the conversion rate of the Class B ordinary shares, which are currently convertible to Class A ordinary shares on a one-to-one (1:1) basis, will change to a one-to-twenty-five (1:25) basis (the “Variation of Class Rights”), meaning 25 class B shares are needed to convert to one Class A share.

Shareholders approved the Reverse Split, Variation of Class Rights, and increase in authorized shares at their extraordinary general meeting on April 15, 2025, and the changes were implemented through an amendment to the company’s charter documents filed on April 28, 2025.

About Bon Natural Life Limited

BON, a Cayman Islands-based company, operates in the natural health and personal care industries. Additional details are available at .

Forward-Looking Statements

This announcement includes “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. These statements can be identified by terms such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or similar expressions. While the Company believes these forward-looking statements are reasonable, it cannot guarantee their accuracy and cautions investors that actual results may differ significantly. These statements reflect current beliefs, expectations, and assumptions regarding the company’s future business, plans, strategies, projections, anticipated events, trends, economic conditions, regulatory activities, and future regulations. Because they relate to the future, these statements are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and often beyond the Company’s control. Therefore, investors should not place undue reliance on them. These risks and uncertainties include, but are not limited to: the completion of the offering, the satisfaction of customary closing conditions, the intended use of proceeds, BON’s limited operating history and historical losses; BON’s ability to raise additional funding; competition from third parties; BON’s ability to obtain, maintain and protect its intellectual property; and BON’s expectations regarding its growth, strategy, and progress. These forward-looking statements are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy and financial needs and involve known and unknown risks and uncertainties. The Company is not obligated to update these statements to reflect new events, circumstances, or changes in expectations, except as required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and in its other filings with the U.S. Securities and Exchange Commission.

Investor Relations Contact:

Cindy Liu | IR

Email: bonnatural@appchem.cn

“`